Sep 9, 2022: NIH NSABB Final Session w/ Renee Wegryzn PhD of Ginkgo Bioworks ginkgobioworks.com

NATIONAL SCIENCE ADVISORY BOARD FOR BIOSECURITY (NSABB)
VIRTUAL MEETING
(Wednesday, September 21, 2022, 1:00:00 PM, 4 hours. All times ET)Show more

Description: The NSABB is a federal advisory committee that addresses issues related to biosecurity and dual use research at the request of the United States Government. The NSABB has up to 25 voting members with a broad range of expertise including molecular biology, microbiology, infectious diseases, biosafety, public health, veterinary medicine, plant health, national security, biodefense, law enforcement, scientific publishing, and other related fields.
Stream:
Author: OSP, NIH
Runtime: 4 hours
Event ID: 46218)

DRAFT AGENDA
1:00 PM – 1:10 PM Meeting Overview and Goals
Lyric Jorgenson, PhD, Acting Associate Director for Science Policy, NIH
Gerald W. Parker, Jr., DVM, PhD, NSABB Chair, Associate Dean for Global One Health, Texas A&M University

1:10 PM – 1:30 PM Working Group Update: Potential Pandemic Pathogen Care and Oversight (P3CO) Policy Review
Gerald W. Parker, Jr., DVM, PhD, NSABB Chair, Associate Dean for Global One Health, Texas A&M University
Syra Madad, DHSc, MSc, MCP, Senior Director, System-wide Special Pathogens Program, NYC Health + Hospitals

1:30 PM – 1:55 PM Public Comments

1:55 PM – 2:25 PM NSABB Discussion

2:25 PM – 2:45 PM Break

DURC STAKEHOLDER SESSION

2:45 PM – 3:45 PM USG DURC Policies Review and Evaluation – Responsibly Communicating Research Methods and Results
Panelists:
• Michael Imperiale, PhD, Arthur F. Thurnau Professor, Department of Microbiology and Immunology, University of Michigan
• Richard Sever, PhD, Co-founder, bioRxiv & medRxiv
Session Goals:
• Assess policies, procedures, and best practices when

NATIONAL SCIENCE ADVISORY
BOARD FOR BIOSECURITY (NSABB)
identifying, reviewing, and mitigating biosecurity concerns in research communications
• Discuss the role and responsibilities of publishers and science communicators in balancing transparency and biosecurity concerns
• Identify potential benefits and challenges with formalizing oversight roles and responsibilities in communicating DURC

3:45 PM – 4:45 PM USG DURC Policies Review and Evaluation – Future Oversight of P3CO and DURC
Panelists:
• Renee Wegrzyn, PhD, VP Business Development, Ginkgo Bioworks
• Marc Lipsitch, DPhil, Director, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health
• Sam Weiss Evans, DPhil, Senior Research Fellow, Harvard Kennedy School
Session Goals:
• Identify potential strengths and weaknesses of an integrated P3CO and DURC oversight framework
• Discuss alternate governance approaches to managing research posing potential biosecurity risks
• Consider pros and cons of various oversight frameworks (e.g., based on types of experiments, lists of agents, etc.)

4:45 PM – 5:00 PM Next Steps and Closing Remarks
Lyric Jorgenson, PhD, Acting Associate Director for Science Policy, NIH
Gerald W. Parker, Jr., DVM, PhD, NSABB Chair, Associate Dean for Global One Health, Texas A&M University